Danimer Scientific, Inc. (DNMRQ)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22.19	59.17	62.79	286.49	377.58	6.26
Cash & Short-Term Investments	22.19	59.17	62.79	286.49	377.58	6.26
Cash Growth	-71.33%	-5.77%	-78.08%	-24.13%	5930.68%	-0.89%
Accounts Receivable	16.12	18.23	22.68	20.73	8.07	5.52
Other Receivables	0.13	0.65	1.64	3.84	-	-
Receivables	16.25	18.88	24.31	24.56	8.07	5.52
Inventory	26.04	25.27	32.74	24.57	13.64	7.04
Prepaid Expenses	5.4	4.71	5.23	4.74	3.09	0.42
Total Current Assets	69.87	108.04	125.07	340.36	402.38	19.24
Property, Plant & Equipment	449.39	464.31	472.98	335.42	126.18	92.41
Goodwill	-	-	-	62.65	-	-
Other Intangible Assets	75.76	77.79	80.94	84.66	1.8	2.05
Long-Term Deferred Charges	1.1	-	-	1.4	-	-
Other Long-Term Assets	16.1	16.54	1.84	0.71	2.43	3.13
Total Assets	643.77	698.13	712.27	838.6	546.2	144.57
Accounts Payable	4.54	5.29	14.98	20.79	10.61	8.12
Accrued Expenses	4.87	3.98	3.24	5.86	6.15	4.04
Current Portion of Long-Term Debt	6.02	1.37	1.97	0.36	25.2	9.28
Current Portion of Leases	3.72	3.34	3.34	3.34	3	2.58
Current Income Taxes Payable	1.08	0.55	0.67	0.5	-	-
Current Unearned Revenue	0.91	1	-	0.21	2.46	4.58
Other Current Liabilities	0.18	0.19	1.09	12.42	3.07	5.68
Total Current Liabilities	21.33	15.72	25.29	43.48	50.49	34.28
Long-Term Debt	381.87	381.44	286.4	260.93	31.39	73.78
Long-Term Leases	21.42	21.93	22.11	22.69	24.18	17.43
Long-Term Deferred Tax Liabilities	-	-	0.2	1.01	-	-
Other Long-Term Liabilities	7.55	1.03	0.66	10.22	84.11	2.5
Total Liabilities	432.18	420.11	334.66	338.33	190.16	128
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	737.46	732.13	676.25	619.15	414.82	66.5
Retained Earnings	-525.88	-454.12	-298.65	-118.89	-58.78	-49.93
Shareholders' Equity	211.59	278.02	377.61	500.27	356.04	16.58
Total Liabilities & Equity	643.77	698.13	712.27	838.6	546.2	144.57
Total Debt	413.04	408.07	313.82	287.32	83.76	103.07
Net Cash (Debt)	-390.85	-348.9	-251.03	-0.83	293.82	-96.81
Net Cash Per Share	-141.43	-136.82	-99.32	-0.36	397.45	-152.85
Filing Date Shares Outstanding	3.02	2.86	2.55	2.52	2.21	3.17
Total Common Shares Outstanding	3.02	2.57	2.55	2.52	2.11	2.77
Working Capital	48.54	92.32	99.78	296.88	351.9	-15.05
Book Value Per Share	70.08	108.15	148.37	198.74	168.47	5.98
Tangible Book Value	135.83	200.23	296.67	352.96	354.24	14.52
Tangible Book Value Per Share	44.99	77.89	116.57	140.22	167.62	5.24
Land	0.1	0.09	0.09	0.09	0.09	0.08
Buildings	2.19	2.19	2.16	2.16	2.09	1.81
Machinery	199.18	198.9	188.22	102.62	67.17	33.6
Construction In Progress	206.62	203	198.55	212.65	36.15	52.4
Leasehold Improvements	110.54	110.53	109.81	27.85	20.93	-

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.